MIDAS PHARMA POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Copy
CopyKey data
Status
KRS number
CopyREGON
CopyNIP/VAT code
CopyVAT registration date
VAT status
Bankruptcy proceedings
MIDAS PHARMA POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Contacts
Registered address
Copy
Website
WWW.MIDAS-PHARMA.COM
A
HighestReliability
A - HighestIncorporation date
03/08/2005Share capital
50,000.00 PLNPrimary activity
Agents specialised in the sale of particular products or ranges of other products (46.18.Z - PKD 2007)Representatives
1Representatives rights
JEŻELI ZARZĄD SPÓŁKI JEST WIELOOSOBOWY, DO SKŁADANIA OŚWIADCZEŃ W ZAKRESIE PRAW I OBOWIĄZKÓW MAJĄTKOWYCH SPÓŁKI ORAZ SKŁADANIA PODPISÓW W IMIENIU SPÓŁKI UPOWAŻNIONYCH JEST DWÓCH CZŁONKÓW ZARZĄDU ŁĄCZNIE ALBO JEDEN CZŁONEK ZARZĄDU ŁĄCZNIE Z PROKURENTEM.Representatives
Business linkages
Premium users: 1.00 credit
Financial report (Okredo)
Premium users: 1.00 credit
People
Representatives
Person  | Title |
|---|---|
K*** H**** S********* | Member |
Persons with Significant Control
Persons with Significant Control
This information is available in our reports and to subscription users.Financial ratios
Net Profit (zł)
5,419,952Net Profit (zł)
5,419,952Financial report (Okredo)
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (zł) |
| Profit before tax (zł) |
| Net Profit (zł) |
Working capital requirement (%) The working capital requirement indicator shows how much funds a company needs to develop and maintain a business. |
| Liquidity ratioliquidityRatio |
| Net profitability (%)This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales. |
| Equity (zł) |
| Current liabilities (zł) |
| Non current liabilities (zł) |
| Non-current Assets (zł) |
| 2022 |
|---|
| 75,041,811 |
| 5,730,311 |
| 4,666,608 |
| 0.21 |
| 2.64 |
| 6.22 |
| 15,044,016 |
| 9,669,513 |
| 9,430 |
| 129,734 |
| 2023 |
|---|
| 74,206,705 |
| 4,025,216 |
| 3,308,929 |
| 0.22 |
| 2.79 |
| 4.46 |
| 16,352,945 |
| 9,086,089 |
| 0 |
| 227,078 |
| 2024 |
|---|
| 85,748,000 |
| 6,663,051 |
| 5,419,952 |
| 0.23 |
| 3.24 |
| 6.32 |
| 19,772,897 |
| 8,928,567 |
| 0 |
| - |
| 2024 |
|---|
| 85,748,000 |
| 6,663,051 |
| 5,419,952 |
| 0.23 |
| 3.24 |
| 6.32 |
| 19,772,897 |
| 8,928,567 |
| 0 |
| - |
Turnover (zł)
2024
Turnover (zł)
85,748,000 zł
16 % *
Profit before tax (zł)
6,663,051 zł66 % *
Net Profit (zł)
5,419,952 zł64 % *
Working capital requirement (%)
0.23 
4.55 % *
Liquidity ratio
3.24 16.13 % *
Net profitability (%)
6.32 %41.70 % *
Equity (zł)
19,772,897 zł21 % *
Current liabilities (zł)
8,928,567 zł
-2 % *
Non current liabilities (zł)
0 zł
- *
Non-current Assets (zł)
-Credit history
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Creditor/Data source | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Documents
MIDAS PHARMA POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ Documents
Date | Description |
|---|---|
07/07/2025 | OD 01.01.2024 DO 31.12.2024 |
02/07/2024 | OD 01.01.2023 DO 31.12.2023 |
05/07/2023 | OD 01.01.2022 DO 31.12.2022 |
29/09/2022 | OD 01.01.2021 DO 31.12.2021 |
30/09/2021 | OD 01.01.2020 DO 31.12.2020 |